Problem-centered consultations for pharmaceutical companies in compliance with new policies for drug inserts and labeling

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: CHEN, Yi-Hsuan (Taiwan Young Pharmacist's Group, Taoyuan County, China Taiwan)
  • Co-author(s): Yi-Hsuan Chen: Taiwan young pharmacists group, Taipei, Taiwan, Province of China
    Huang-Tz Ou: Department of Pharmacy, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Province of China
    Wei Ho: Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan, Province of China
    Yuu-Hueih Hsu: Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Province of China
    Hung-Chang Chou: School of pharmacy, Taipei Medical University, Taipei, Taipei, Taiwan, Province of China
  • Abstract:

    Background

    According to the regulation formulated by Taiwan Food and Drug Administration (TFDA) on March 1st 2016, pharmaceutical companies are obligated to provide updated the non-prescription medications (NPM) inserts and labeling with improved legibility for both general population and the visually disabled by the end of 2019. However,..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login